Biotech & Life SciencesClimate & EnergyConsumerE-Commerce & MarketplaceFintechPropTechInfrastructure & CloudManufacturing
Colt Ventures is a diversified family office founded in 2003 by Darren Blanton, headquartered in Dallas, TX. The firm invests personal capital across private and public markets, with sector focus including biotechnology, oil & gas, technology, real estate, consumer & retail, financial services, and special situations.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (75% of deals). Average disclosed round size is $108.8M (across 6 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAlterome Therapeutics, Inc. | Series B | $35M | Apr 2024 |
 Odyssey Therapeutics | Series B | $168M | Oct 2022 |
| Odyssey Therapeutics | Series A | $218M | Dec 2021 |
 Rumble | Unknown | — | May 2021 |
| SSilverback Therapeutics | Series B | — | Jan 2020 |
 ReCode Therapeutics | Series B | $50M | — |
 Alterome Therapeutics | Series B | $132M | — |
| RReCode | Series B | $50M | — |
Top Co-Investors
OrbiMed7 shared
Alexandria Venture Investments2 shared
Logos Capital2 shared
SR One2 shared
Correlation Ventures2 shared
Foresite Capital2 shared
HBM Healthcare Investments2 shared
Sanofi Ventures2 shared
Leaps by Bayer2 shared
Solasta Ventures2 shared
MPM Capital2 shared
Amgen Ventures2 shared
Matrix Partners2 shared
Osage University Partners2 shared
Pfizer Ventures2 shared
Blue Owl Capital2 shared
Boxer Capital2 shared
Canaan Partners2 shared
Nextech Invest Ltd.2 shared
The Invus Group, LLC2 shared
Last updated: 8 September 2026